Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Entheon Biomedical Corp. (ENTBF)
:ENTBF
ENTBF Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.02 - $0.29
Previous CloseN/A
Volume3.65K
Average Volume (3M)1.54K
Market Cap
$1.94M
Enterprise Value$1.85M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.79
Next Earnings
Apr 01, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding8,858,926
10 Day Avg. Volume2,750
30 Day Avg. Volume1,538
Standard Deviation0.34
R-Squared0.12
Alpha-0.04
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)40.77
Price to Cash Flow (P/CF)-10.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Entheon Biomedical News
PremiumCompany Announcements
Entheon Biomedical Secures $500,000 in Private Placement
PremiumCompany Announcements
Entheon Biomedical Announces New Private Placement Financing
PremiumCompany Announcements
Entheon Biomedical Completes $147.5K Private Placement---
Options Prices
Currently, No data available
---
Ownership Overview
ENTBF FAQ
What was Entheon Biomedical Corp.’s price range in the past 12 months?
Entheon Biomedical Corp. lowest stock price was $0.02 and its highest was $0.29 in the past 12 months.
What is Entheon Biomedical Corp.’s market cap?
Entheon Biomedical Corp.’s market cap is $1.94M.
When is Entheon Biomedical Corp.’s upcoming earnings report date?
Entheon Biomedical Corp.’s upcoming earnings report date is Apr 01, 2025 which is in 40 days.
How were Entheon Biomedical Corp.’s earnings last quarter?
Entheon Biomedical Corp. released its earnings results on Oct 24, 2024. The company reported -$0.005 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.005.
Is Entheon Biomedical Corp. overvalued?
According to Wall Street analysts Entheon Biomedical Corp.’s price is currently Overvalued.
Does Entheon Biomedical Corp. pay dividends?
Entheon Biomedical Corp. does not currently pay dividends.
What is Entheon Biomedical Corp.’s EPS estimate?
Entheon Biomedical Corp.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Entheon Biomedical Corp. have?
Entheon Biomedical Corp. has 8,858,926 shares outstanding.
What happened to Entheon Biomedical Corp.’s price movement after its last earnings report?
Entheon Biomedical Corp. reported an EPS of -$0.005 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Entheon Biomedical Corp.?
Currently, no hedge funds are holding shares in ENTBF
---
Company Description
Entheon Biomedical Corp.
Entheon Biomedical Corp is a biotechnology research and development company. It is committed towards developing and safe and effective psychedelic medicines in order to provide patients with access to evidence-based treatments for addiction disorders. It generates revenue through the sale of products to physicians, clinics and licensed psychiatrists in the United States, certain countries in the European Union and throughout Canada.
---
Technical Analysis
Numinus Wellness
―
Neo Performance Materials Inc
―
Cybin
―
Red Light Holland
―
HAVN Life Sciences
―
---